• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SelectQuote Unveils New Program Designed to Elevate Health Plan Performance by Improving Medication Adherence for Polychronic Medicare Beneficiaries

    7/17/25 7:00:00 AM ET
    $SLQT
    Specialty Insurers
    Finance
    Get the next $SLQT alert in real time by email

    SelectQuote, Inc. (NYSE:SLQT) (the "Company"), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced the expanded launch of their innovative concierge-like service designed to specifically improve medication adherence for Medicare beneficiaries managing multiple chronic conditions and complex medication regimens. SelectQuote's SelectRx pharmacy recently trialed a new approach with a regional health plan that demonstrated over 90% adherence, strengthening HEDIS Star ratings across the triple-weighted cholesterol, diabetes and hypertension measures. The Company plans to expand to additional payers this calendar year and will roll out across SelectRx's pharmacy platform in 2026.

    This program further demonstrates SelectQuote's deep commitment to driving better health outcomes and greater value for both patients and payer partners. This high-touch solution is purpose-built to address the critical challenge of medication non-adherence, which often leads to preventable hospitalizations, adverse drug interactions, and escalating healthcare costs for the Medicare system.

    SelectRx designed the program to proactively identify and engage high- and medium-risk patients, prioritizing those with a higher likelihood of adherence gaps. These beneficiaries stand to benefit most from enhanced support in managing their complex medication schedules. SelectQuote aims to help patients overcome adherence barriers through escalations to its clinical pharmacist team, who can provide specialized intervention. The Company also plans to launch a complementary program for lower risk members to support their continued medication adherence.

    "We are incredibly excited about this initiative and its potential to significantly improve medication management for our most vulnerable Medicare beneficiaries," said Bob Grant, President of SelectQuote. "Our SelectRx pharmacy offering already dramatically improves medication adherence and other health measures through timely, convenient delivery and easy-to-use packaging. We believe this new concierge-like program underscores that we are much more than a traditional Medicare broker helping beneficiaries find the right health plan. The program now takes our foundational commitment to improving Medicare patient outcomes to the next level. It embodies our mission to provide ongoing, personalized support that directly impacts patient health and well-being, significantly reducing costly acute episodes and improving quality of life."

    Forward Looking Statements

    This release contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," "expect," "continue," "will," "anticipate," "seek," "estimate," "intend," "plan," "projection," "would" and "outlook," or the negative version of those words or other comparable words or phrases of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.

    There are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the following: our reliance on a limited number of insurance carrier partners and any potential termination of those relationships or failure to develop new relationships; existing and future laws and regulations affecting the health insurance market; changes in health insurance products offered by our insurance carrier partners and the health insurance market generally; insurance carriers offering products and services directly to consumers; changes to commissions paid by insurance carriers and underwriting practices; competition with brokers, exclusively online brokers and carriers who opt to sell policies directly to consumers; competition from government-run health insurance exchanges; developments in the U.S. health insurance system; our dependence on revenue from carriers in our senior segment and downturns in the senior health as well as life, automotive and home insurance industries; our ability to develop new offerings and penetrate new vertical markets; risks from third-party products; failure to enroll individuals during the Medicare annual enrollment period; our ability to attract, integrate and retain qualified personnel; our dependence on lead providers and ability to compete for leads; failure to obtain and/or convert sales leads to actual sales of insurance policies; access to data from consumers and insurance carriers; accuracy of information provided from and to consumers during the insurance shopping process; cost-effective advertisement through internet search engines; ability to contact consumers and market products by telephone; global economic conditions, including inflation; disruption to operations as a result of future acquisitions; significant estimates and assumptions in the preparation of our financial statements; impairment of goodwill; potential litigation and other legal proceedings or inquiries; our existing and future indebtedness; our ability to maintain compliance with our debt covenants; access to additional capital; failure to protect our intellectual property and our brand; fluctuations in our financial results caused by seasonality; accuracy and timeliness of commissions reports from insurance carriers; timing of insurance carriers' approval and payment practices; factors that impact our estimate of the constrained lifetime value of commissions per policyholder; changes in accounting rules, tax legislation and other legislation; disruptions or failures of our technological infrastructure and platform; failure to maintain relationships with third-party service providers; cybersecurity breaches or other attacks involving our systems or those of our insurance carrier partners or third-party service providers; our ability to protect consumer information and other data; failure to market and sell Medicare plans effectively or in compliance with laws; and other factors related to our pharmacy business, including manufacturing or supply chain disruptions, access to and demand for prescription drugs, and regulatory changes or other industry developments that may affect our pharmacy operations. For a further discussion of these and other risk factors that could impact our future results and performance, see the section entitled "Risk Factors" in the most recent Annual Report on Form 10-K (the "Annual Report") and subsequent periodic reports filed by us with the Securities and Exchange Commission. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

    About SelectQuote:

    Founded in 1985, SelectQuote (NYSE:SLQT) pioneered the model of providing unbiased comparisons from multiple, highly-rated insurance companies, allowing consumers to choose the policy and terms that best meet their unique needs. Two foundational pillars underpin SelectQuote's success: a strong force of highly-trained and skilled agents who provide a consultative needs analysis for every consumer, and proprietary technology that sources and routes high-quality leads. Today, the Company operates an ecosystem offering high touchpoints for consumers across insurance, pharmacy, and virtual care.

    With an ecosystem offering engagement points for consumers across insurance, Medicare, pharmacy, and value-based care, the company now has three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, and SelectQuote Life. SelectQuote Senior serves the needs of a demographic that sees around 10,000 people turn 65 each day with a range of Medicare Advantage and Medicare Supplement plans. SelectQuote Healthcare Services is comprised of the SelectRx Pharmacy, a Patient-Centered Pharmacy Home™ (PCPH) accredited pharmacy, SelectPatient Management, a provider of chronic care management services, and Healthcare Select, which proactively connects consumers with a wide breadth of healthcare services supporting their needs.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250717149777/en/

    Investor Relations:

    Sloan Bohlen

    877-678-4083

    [email protected]

    Media:

    Matt Gunter

    913-286-4931

    [email protected]

    Get the next $SLQT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $SLQT

    DatePrice TargetRatingAnalyst
    5/21/2025$2.75Hold
    Jefferies
    9/30/2024$4.50Buy
    Craig Hallum
    2/29/2024$5.00Outperform
    Noble Capital Markets
    4/1/2022$4.00Neutral
    Credit Suisse
    2/8/2022$9.00 → $5.00Equal Weight
    Barclays
    2/8/2022$13.00 → $3.00Sector Perform
    RBC Capital
    2/8/2022$20.00 → $4.00Overweight → Neutral
    Piper Sandler
    2/8/2022$14.00 → $4.00Outperform → Neutral
    Credit Suisse
    More analyst ratings

    $SLQT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Devine Denise L bought $14,460 worth of shares (4,000 units at $3.62), increasing direct ownership by 1% to 318,583 units (SEC Form 4)

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      3/19/25 4:54:26 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SEC Form 4: Matthews Joshua Brandon bought $113,295 worth of shares (97,500 units at $1.16), increasing direct ownership by 32% to 400,937 units

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      9/18/23 6:29:01 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SEC Form 4: Grant William Thomas Iii bought $179,250 worth of shares (150,000 units at $1.20), increasing direct ownership by 9% to 1,913,851 units

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      9/18/23 6:28:20 PM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    SEC Filings

    See more
    • SelectQuote Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - SelectQuote, Inc. (0001794783) (Filer)

      7/2/25 5:26:27 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SEC Form 10-Q filed by SelectQuote Inc.

      10-Q - SelectQuote, Inc. (0001794783) (Filer)

      5/12/25 4:12:38 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SelectQuote Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - SelectQuote, Inc. (0001794783) (Filer)

      5/12/25 7:33:00 AM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SelectQuote Unveils New Program Designed to Elevate Health Plan Performance by Improving Medication Adherence for Polychronic Medicare Beneficiaries

      SelectQuote, Inc. (NYSE:SLQT) (the "Company"), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced the expanded launch of their innovative concierge-like service designed to specifically improve medication adherence for Medicare beneficiaries managing multiple chronic conditions and complex medication regimens. SelectQuote's SelectRx pharmacy recently trialed a new approach with a regional health plan that demonstrated over 90% adherence, strengthening HEDIS Star ratings across the triple-weighted cholesterol, diabetes and hypertension measures. The Company plans to expand to additional payers this calendar year a

      7/17/25 7:00:00 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • SelectQuote Mourns the Passing of Tom Grant, Vice Chairman of the Board of Directors

      SelectQuote, Inc. (NYSE:SLQT) announced today that William Thomas (Tom) Grant II, Vice Chairman and former President of SelectQuote, passed away on July 1, 2025, following a battle with cancer. Tom was instrumental in formulating and executing SelectQuote's strategy over the past fifteen years as the business evolved from a term life insurance brokerage into a diversified insurance and rapidly-growing healthcare services business. His strategic insights and dedication were pivotal to the company's success. Tom also personally touched the lives of thousands of SelectQuote associates and their families with his wit, warmth, and ever-present smile. "Tom's mark on SelectQuote was profound a

      7/2/25 4:15:00 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SelectQuote's Highly-Satisfied Insurance Customers Award the Company a Net Promoter Score of 58, Considered "Great"

      The new achievement adds to SelectQuote Insurance Services' recent recognition in USA Today's "America's Best Customer Service" List for 2025. SelectQuote, Inc. (NYSE:SLQT) (the "Company"), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced the results of its on-going Net Promoter Score (NPS) surveys of customers in its Senior Health, Life, and Auto & Home insurance businesses. SelectQuote Insurance Services' overall Net Promoter Score of 58 falls within the range considered "Great" by established NPS standards. SelectQuote CEO Tim Danker said, "For over 40 years, our highly-skilled agents have provided an outs

      5/27/25 8:00:00 AM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CHIEF OPERATING OFFICER Grant William Thomas Iii transferred by will 448,474 shares), increasing direct ownership by 20% to 2,672,050 units (SEC Form 4)

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      7/3/25 9:03:53 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • PRESIDENT Grant Robert Clay transferred by will 448,474 shares), increasing direct ownership by 22% to 2,464,408 units (SEC Form 4)

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      7/3/25 9:03:07 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • Director Devine Denise L bought $14,460 worth of shares (4,000 units at $3.62), increasing direct ownership by 1% to 318,583 units (SEC Form 4)

      4 - SelectQuote, Inc. (0001794783) (Issuer)

      3/19/25 4:54:26 PM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Jefferies initiated coverage on SelectQuote with a new price target

      Jefferies initiated coverage of SelectQuote with a rating of Hold and set a new price target of $2.75

      5/21/25 8:59:27 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • Craig Hallum initiated coverage on SelectQuote with a new price target

      Craig Hallum initiated coverage of SelectQuote with a rating of Buy and set a new price target of $4.50

      9/30/24 8:47:10 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • Noble Capital Markets initiated coverage on SelectQuote with a new price target

      Noble Capital Markets initiated coverage of SelectQuote with a rating of Outperform and set a new price target of $5.00

      2/29/24 8:29:44 AM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by SelectQuote Inc. (Amendment)

      SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)

      1/29/24 3:26:24 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SEC Form SC 13G/A filed by SelectQuote Inc. (Amendment)

      SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)

      2/14/23 1:42:28 PM ET
      $SLQT
      Specialty Insurers
      Finance
    • SEC Form SC 13G/A filed by SelectQuote Inc. (Amendment)

      SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)

      2/1/23 4:54:05 PM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Leadership Updates

    Live Leadership Updates

    See more
    • SelectQuote Names Ryan Clement as Chief Financial Officer

      Clement has served as Interim CFO since May 2022 SelectQuote, Inc. (NYSE:SLQT) today announced that the Board of Directors appointed Ryan Clement, SVP of Financial Planning & Analysis, to serve as the company's Chief Financial Officer. Clement was named interim CFO in May 2022. CEO Tim Danker commented, "Over the last year, Ryan has excelled as our Interim CFO and has demonstrated both the financial acumen and leadership qualities we are looking for in the company's next permanent CFO. Ryan has played a critical role in our strategic redesign that has vastly improved SelectQuote's operating results and financial stability and positions the company to execute on our objectives in the futur

      2/22/23 8:00:00 AM ET
      $SLQT
      Specialty Insurers
      Finance

    $SLQT
    Financials

    Live finance-specific insights

    See more
    • SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2025 Results

      Third Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $408.2 million Net income of $26.0 million Adjusted EBITDA* of $37.7 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.500 billion to $1.575 billion Net income (loss) expected in a range of $(1) million to $28 million Adjusted EBITDA* expected in a range of $115 million to $140 million Third Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $169.4 million Adjusted EBITDA* of $45.7 million Approved Medicare Advantage policies of 168,001 Healthcare Services Revenue of $189.6 million Adjusted EBITDA* of $6.4 million 105,523 SelectRx members Li

      5/12/25 7:30:00 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • SelectQuote to Release Fiscal Third Quarter 2025 Earnings on May 12

      SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its third quarter 2025 financial results before market open on Monday, May 12, 2025. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (May 12, 2025) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I54780976. After registering, a confirmation will be sent via email, including dial in details and unique conference call codes for entry. Registratio

      5/5/25 8:00:00 AM ET
      $SLQT
      Specialty Insurers
      Finance
    • SelectQuote, Inc. Reports Second Quarter of Fiscal Year 2025 Results

      Second Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $481.1 million Net income of $53.2 million Adjusted EBITDA* of $87.5 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.500 billion to $1.575 billion Net income (loss) expected in a range of $(24) million to $11 million Adjusted EBITDA* expected in a range of $115 million to $140 million Second Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $255.6 million Adjusted EBITDA* of $100.5 million Approved Medicare Advantage policies of 247,849 Healthcare Services Revenue of $183.4 million Adjusted EBITDA* of $2.2 million 96,695 Se

      2/10/25 4:05:00 PM ET
      $SLQT
      Specialty Insurers
      Finance